Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
trending now
trending in pharma/biotech
trending in device
pharmagather
advertise
Legal Help
login/register
You are here
Home
» U.S. FDA advisors set to review opioid constipation drugs
U.S. FDA advisors set to review opioid constipation drugs
U.S. FDA advisors set to review opioid constipation drugs
Submitted by
admin
on June 9, 2014 - 11:04am
Source:
Yahoo/Reuters
News Tags:
FDA
opioid-induced constipation
Salix
Relistor
Cubist Pharmaceuticals
Entereg
AstraZeneca
Nektar
Naloxegol
Headline:
U.S. FDA advisors set to review opioid constipation drugs
